ReviewDiabetes & metabolism journal2021

Rho-Kinase as a Therapeutic Target for Nonalcoholic Fatty Liver Diseases.

Inês Sousa-Lima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.